NCT05765617View on ClinicalTrials.gov

Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
COVID-19
Interventions
DRUG

Calcitriol

The treatment group received calcitriol 2x400 iu per day for five days. Calcitriol uses Oscal, obtained from Kalbe Pharma

OTHER

Placebo

Placebo give 2x1 per day for five day

Trial Locations (1)

57161

Universitas Sebelas Maret Hospital, Sukoharjo

All Listed Sponsors
lead

Universitas Sebelas Maret

OTHER